Notably, while the genetics studies pointed to the importance of the A53T mutation in α-synuclein as driving an autosomal dominant form of disease, the immunolabeling studies revealed that α-synuclein mutations are not required for the formation of LBs or PD. The gene discussed is SNCA; the disease is Parkinson disease.